Design, Synthesis, and Evaluation of Selective Ubiquitin-Specific Protease 11 (USP11) Inhibitors.

ABSTRACT: Ubiquitin-specific protease 11 (USP11) is a promising anticancer target, but selective inhibitor development has proved to be challenging. Here, we designed and synthesized selective USP11 inhibitors based on a previously reported covalent probe (N-benzyl-4-(2-chloroacetyl)-1-methyl-1H-pyrrole-2-carboxamide, compound 2) that is a more potent inhibitor of USP4 than USP11. Compound 7, derived from 2 by the introduction of a piperidine moiety, exhibited an IC₅₀ of 2.59 μM, while the replacement of chloroacetyl with a methyl sulfonylpiperazine moiety (compound 26) displayed equivalent potency. Sustained inhibition of USP11 consistent with covalent binding was observed in a jump dilution assay, and the compounds displayed significantly lower

SUBMITTER: Hassan MA 

PROVIDER: S-EPMC12713474 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature